Simcere Pharma shareholders approve all resolutions at AGM

Simcere Pharmaceutical Group Limited (HKEX: 2096) announced the results of its Annual General Meeting (AGM) held on June 13, 2025, where all proposed resolutions were passed by shareholders. Key outcomes included the approval of the audited consolidated financial statements, the re-election of retiring directors, and the re-appointment of KPMG as auditors. Shareholders also authorized a final dividend of RMB0.16 per share for the year ended December 31, 2024, payable in HKD based on an exchange rate of HKD1 against RMB0.91532, equivalent to HKD0.17480 per share. The company set the record date for dividend entitlements as Tuesday, June 24, 2025, with payment scheduled on or before Monday, July 14, 2025. The meeting also granted general mandates to the directors for share allotment and repurchase.